Exscientia PLC (EXAI) - Pendapatan lan volume dodolan

Exscientia plc (EXAI) is developing an AI ecosystem for precision drug design, deeply integrating its software into the processes of pharmaceutical behemoths. The company's sales dynamics clearly demonstrate market demand, while 0.02 reflects the latest metric value. The molecular linkage database ensures long-term royalties, and management is successfully consolidating technological platforms following acquisitions while maintaining the trust of key counterparties.

Exscientia Inc. (EXAI) - Pendapatan perusahaan saka 04.07.2022 nganti 30.11.2024

Rincian metrik komprehensif lan analitis Exscientia PLC (EXAI)

- nilai pasar lan prakiraan target analis:

Bagan bursa Exscientia Inc.|EXAI - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Kapitalisasi pasar Exscientia plc|EXAI - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- rincian nilai buku perusahaan:

Nilai Akuntansi Saham Exscientia|EXAI - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Aset Bersih exscientia.ai|EXAI - Aset Agregat Perusahaan

- statistik kawajiban utang lan likuiditas:

- indikator bathi lan kelipatan valuasi:

EXAI - Bathi resik|Prakiraan bathi perusahaan Exscientia plc|EXAI - Pangali P/E|Pangali Forward P/E Exscientia Inc.|EXAI - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Exscientia plc|EXAI - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Exscientia|EXAI - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan exscientia.ai|EXAI - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Exscientia plc

- indikator volume dodolan lan pendapatan:

EXAI - Pendapatan lan volume dodolan|Volume dodolan mangsa ngarep perusahaan Exscientia Inc.|EXAI - Multiplikator P/S|Rasio kapitalisasi marang dodolan sing dikarepake Exscientia plc

Ringkesan analisis perusahaan:EXAI (exscientia.ai)

To minimize investment risks, it is necessary to track actual revenue, which confirms the execution of business plans and the probability of capital drawdown. The current value of 0.02 in the volume of Exscientia plc (EXAI) realized products reflects the monetization efficiency of its AI platform, where the speed of molecule design directly converts into revenue from strategic partnerships with global pharmaceutical behemoths.

Perusahaan pesaing